Recent developments to share with you

The Most Beautiful Women's Day – Flowers Are Blooming for You

2022-09-12


At Kangchuanji, there is a group of women who are independent, confident, gentle, and hardworking. In their respective roles, they take on responsibilities with dedication, paint their dreams with passion, and build their careers. They are a beautiful presence and the "half the sky" that holds up Kangchuanji's many achievements.

In the warm spring of March, Women's Day arrived as promised. On this special day, taking some time to care for yourself is what truly matters. On the afternoon of March 8, the women of Kangchuanji gathered in the main conference room for a floral art workshop, experiencing the unique charm of flower arranging.

Surrounded by a sea of fragrant blossoms, the flower arranging activity began. Choosing flowers, trimming stems, and arranging bouquets – the women of Kangchuanji used their creativity to capture the essence of spring in their floral designs, producing one unique and springfilled piece after another.

Everyone enjoyed the fun of flower arranging amid laughter and cheerful conversation. Before they knew it, the event came to a close. The participants left with their own handcrafted floral creations, along with exclusive chocolates and movie tickets, bringing a wonderful end to the activity.

 

Keywords:

Related information

Bountiful Results | January–July 2026: Kangchuanji Pharmaceutical, in collaboration with multiple pharmaceutical companies, secured approval or passed the evaluation for 15 product specifications.

From January to July 2026, Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd., leveraging its deep-rooted pharmaceutical R&D expertise and mature end-to-end CDMO capabilities, has provided robust support for the innovative R&D and commercialization of its partner companies, achieving further regulatory‑review milestones in collaboration with multiple partners. According to the NMPA’s public announcement of drug approval documents, a total of 12 drug products (covering 15 specifications) have been successfully approved or passed consistency evaluation, demonstrating significant results in translating innovative research into tangible outcomes.

2026-08-04

CDE Announcement: Updated Guidelines for Pediatric Medicines! “Technical Guidance on the Application of Physiologically Based Pharmacokinetic Models in Drug Development for Pediatric Populations (Draft for Public Comment)”

On August 17, the CDE released a draft of the “Technical Guidance for the Application of Physiologically Based Pharmacokinetic Models in Pediatric Drug Development” for public comment.

2024-10-27

Good news keeps pouring in: Jiuzhou Pharmaceutical’s Kangchuanji Pharmaceutical has helped its partner obtain marketing approval for Rosuvastatin–Ezetimibe Tablets (I).

Good news keeps pouring in: Jiuzhou Pharmaceutical’s Kangchuanji Pharmaceutical has helped its partner obtain marketing approval for Rosuvastatin–Ezetimibe Tablets (I).

2026-07-03